A carregar...
Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial
Chronic low back pain (LBP) is a common condition, usually with the involvement of nociceptive and neuropathic pain components, high economic burden and impact on quality of life. Cebranopadol is a potent, first-in-class drug candidate with a novel mechanistic approach, combining nociceptin/orphanin...
Na minha lista:
| Publicado no: | Pain |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5761752/ https://ncbi.nlm.nih.gov/pubmed/28644196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/j.pain.0000000000000986 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|